‘Bioinspired Nanofibrous Gel for Tissue Engineering of Cartilage and Bone’ (FIBROGEL) aims to design an implant with unique properties which can influence local tissue regeneration. Using high performance materials and advanced nanotechnology, the project represents a radical step in treating injury or diseases such as osteoarthritis and osteoporosis, and will have a long-term impact on a variety of fields such as nanobioengineering and regenerative medicine.
FIBROGEL is one of just seven projects selected from a total of 65 submitted to EULANEST, an initiative funded under the EU’s 6th EU Framework Programme for Research and Development (FP6). EULANEST’s aim is to promote and coordinate cooperation in science and technology between EU member states and Latin American countries, and FIBROGEL’s scientific partners include groups in both Brazil and Argentina.
“We’ve already had some positive results in the three months that the project has been running, both from my group and the Argentinian side,” says George, ICREA Research Professor and head of IBEC’s Molecular Dynamics at Cell–Biomaterial Interface group. “We’re delighted to receive this recognition and are looking forward to achieving further great outcomes within the supportive framework of EULANEST.”
For more information about FIBROGEL and EULANEST, seewww.ibecbarcelona.eu/images/stories/noticies/eulanest_joint%20call_brochurea5_small.pdf
